Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
复制标题
DOI：
10.1016/j.jsat.2021.108275
复制
发表时间：
2021-09
影响因子：
3.9
通讯作者：
MassJCOIN Research Group
中科院分区：
文献类型：
--
作者：
Evans EA;Stopka TJ;Pivovarova E;Murphy SM;Taxman FS;Ferguson WJ;Bernson D;Santelices C;McCollister KE;Hoskinson R Jr;Lincoln T;Friedmann PD;MassJCOIN Research Group
美国阿片类药物危机的一个主要驱动因素是获得有效治疗阿片类药物使用障碍 (MOUD) 药物的机会有限，这些药物可降低用药过量风险。传统上，美国的看守所和监狱在被监禁的 OUD 患者返回社区之前不会启动或维持 MOUD，这使他们面临服药过量致死的高风险。 2018 年的一项法律（第 208 章）使马萨诸塞州 (MA) 成为第一个要求五个县监狱提供 FDA 批准的所有 MOUD（纳曲酮 [NTX]、丁丙诺啡 [BUP] 和美沙酮）的州。 Chapter 208 设立了一个为期 4 年的试点计划，以扩大在五个监狱中获得 FDA 批准的所有 MOUD 形式的机会，另外两个马萨诸塞州监狱自愿加入了这一计划。该法律规定，对于在拘留前收到 MOUD 的个人，应继续进行 MOUD；对于被判刑的个人，应在释放前酌情启动 MOUD。监狱还必须促进释放后社区内 MOUD 的继续进行。马萨诸塞州司法社区阿片类药物创新网络 (MassJCOIN) 与这七个不同的监狱、马萨诸塞州公共卫生部和社区治疗提供者合作，开展第 208 章的 1 类混合有效性实施研究。我们将：(1) 对在监狱中接受 NTX、BUP、美沙酮或未接受 MOUD 的 OUD 被监禁者进行纵向治疗结果研究，以检查释放后 MOUD 的启动、参与和保留，以及致命和非致命的情况阿片类药物过量和累犯； (2) 进行实施研究，以了解促进和阻碍在监狱中提供 MOUD 和社区护理协调的系统性和背景因素，以及优化监狱中 MOUD 交付以及与社区合作伙伴协调护理的策略； (3)计算监狱内实施MOUD对惩教系统的成本，并从国家政策制定者和社会角度进行经济评估，比较出狱前MOUD与匹配控制中无MOUD的价值。 MassJCOIN 在 2020 年 3 月 COVID-19 大流行开始之前的前六个月取得了重大进展。参与的监狱限制了非必要人员的进入，制定了其他 COVID-19 缓解政策，并修改了 MOUD 编程。 MassJCOIN 根据这一新现实调整研究活动，努力记录和解释 COVID-19 对每个目标的影响。目标仍然是得出对刑事司法环境中 OUD 的政策和实践有直接影响的调查结果。
A major driver of the U.S. opioid crisis is limited access to effective medications for opioid use disorder (MOUD) that reduce overdose risks. Traditionally, jails and prisons in the U.S. have not initiated or maintained MOUD for incarcerated individuals with OUD prior to their return to the community, which places them at high risk for fatal overdose. A 2018 law (Chapter 208) made Massachusetts (MA) the first state to mandate that five county jails deliver all FDA-approved MOUDs (naltrexone [NTX], buprenorphine [BUP], and methadone). Chapter 208 established a 4-year pilot program to expand access to all FDA-approved forms of MOUD at five jails, with two more MA jails voluntarily joining this initiative. The law stipulates that MOUD be continued for individuals receiving it prior to detention and be initiated prior to release among sentenced individuals where appropriate. The jails must also facilitate continuation of MOUD in the community on release. The Massachusetts Justice Community Opioid Innovation Network (MassJCOIN) partnered with these seven diverse jails, the MA Department of Public Health, and community treatment providers to conduct a Type 1 hybrid effectiveness-implementation study of Chapter 208. We will: (1) Perform a longitudinal treatment outcome study among incarcerated individuals with OUD who receive NTX, BUP, methadone, or no MOUD in jail to examine postrelease MOUD initiation, engagement, and retention, as well as fatal and nonfatal opioid overdose and recidivism; (2) Conduct an implementation study to understand systemic and contextual factors that facilitate and impede delivery of MOUDs in jail and community care coordination, and strategies that optimize MOUD delivery in jail and for coordinating care with community partners; (3) Calculate the cost to the correctional system of implementing MOUD in jail, and conduct an economic evaluation from state policy-maker and societal perspectives to compare the value of MOUD prior to release from jail to no MOUD among matched controls. MassJCOIN made significant progress during its first six months until the COVID-19 pandemic began in March 2020. Participating jail sites restricted access for nonessential personnel, established other COVID-19 mitigation policies, and modified MOUD programming. MassJCOIN adapted research activities to this new reality in an effort to document and account for the impacts of COVID-19 in relation to each aim. The goal remains to produce findings with direct implications for policy and practice for OUD in criminal justice settings.
登录
查看更多内容
影响因子：
3.5
作者：
Friedmann PD;Hoskinson R;Gordon M;Schwartz R;Kinlock T;Knight K;Flynn PM;Welsh WN;Stein LA;Sacks S;O'Connell DJ;Knudsen HK;Shafer MS;Hall E;Frisman LK;Mat Working Group Of CJ-Dats
通讯作者：
Mat Working Group Of CJ-Dats
影响因子：
4.2
作者：
Brinkley-Rubinstein, Lauren;Peterson, Meghan;Rich, Josiah D.
通讯作者：
Rich, Josiah D.
影响因子：
3.5
作者：
Becan, Jennifer E;Bartkowski, John P;Aarons, Gregory A
通讯作者：
Aarons, Gregory A
影响因子：
4.2
作者：
Magura, Stephen;Lee, Joshua D.;Rosenblum, Andrew
通讯作者：
Rosenblum, Andrew
影响因子：
4.2
作者：
Mark, TL;Woody, GE;Kleber, HD
通讯作者：
Kleber, HD